Sony Buys Silvergate

Sony buys Silvergate.
   
Sony Pictures Television buys Silvergate Media from its management and Shamrock Capital for $195 million.
   
Silvergate focuses on developing, producing, and licensing children’s animation.  It was founded in 2011 with the rights purchase of two preschool properties.  The company has since expanded its intellectual property and opened out its range with shows such as ‘The Octonauts’, ‘Peter Rabbit’, and ‘Sunny Day’.  Silvergate has a strong and growing presence in China, working with firms there to effectively monetize intellectual property with its partners.
   
This deal comes as Sony looks to push deeper into kids’ television, with its Sony Pictures Animation arm unveiling plans to expand into television series.  It will also open out Sony Pictures Television production interests, which include ‘The Crown’ producer Left Bank and Stellify Media.
   
Mike Hopkins of SPT said: ‘“We are excited to extend our capabilities and gain valuable children’s intellectual property to bolster our entry into the kids’ space.  Silvergate gives us a great building block to expand into this genre in a meaningful way.’
   
Waheed Alli of Silvergate said: ‘We are all excited about joining SPT and the creative teams within the SPT family.  2020 will see a new and strong development slate coming to market with some exciting new series in the pipeline.’
   
Will Wynperle of Shamrock Capital said: ‘This is the beginning of an exciting new chapter for the team at Silvergate.  Over the past several years, the company has grown its portfolio of brands, many of which are viewed on a global basis.  We have enjoyed working with the Silvergate team over the past several years and they are excited about their new partnership with SPT.’
   
Silvergate will continue to be managed by CEO Waheed Alli and William Astor will continue as Chairman.
   
Latham & Watkins served as legal advisor to Sony Pictures Television.
   
Alvarium served as financial advisor to Silvergate Media.  Foot Anstey served as legal advisor.

Comments

Post a Comment

Popular posts from this blog

Pepsi Buys Rockstar

Pepsi buys Rockstar .     P epsiCo buys Rockstar Energy Beverages for $3.85 billion.     Founded in 2001, Rockstar is drinks designed for people leading an active lifestyle. Available in 20 flavors at convenience and grocery stores in 30 countries. Distributed by PepsiCo in North America since 2009. Supporting the Rockstar lifestyle across the globe through action sports, motorsports, and live music. Pepsi's energy portfolio also includes Kickstart , GameFuel, and Amp Energy.     The deal reflects the shift from reliance on sales of sugary, fizzy drinks toward options ranging from tea and coffee to still and sparkling water varieties, which appeal to health-conscious and younger consumers. Neither PepsiCo nor Coca-Cola owns a major brand in the energy drinks category, which is forecast to grow to more than $80 billion over the next five years and is now dominated by Red Bull.     2 00 countries and territories around the world enjoy ...
Read more

Compass Buys Marucci

Compass buys Marucci.     Compass Diversified Holdings buys Marucci Sports for $200 million.     Marucci Sports was founded in 2009 by Kurt Ainsworth, a retired pitcher for the San Francisco Giants and Baltimore Orioles, Joe Lawrence, a former second baseman for the Toronto Blue Jays, and Reed Dickens, a former White House Assistant Press Secretary under George W. Bush.     Marucci ’s first buy was Marucci Bat Company, launched out of a backyard shed in 2004. Ainsworth then led the buyout of an Amish-run Pennsylvania wood mill in 2008. This solidified Marucci's superior wood supply, and it still supplies all Marucci's wood today. In 2017 Marucci bought Victus , a baseball equipment maker known for its edgy designs and big attitude.     With vertically cohesive wood bat production, a global supplier group, and a client base of MVPs and World Series winners, Marucci and Victus are the top two bats among Big League players. T...
Read more

Gilead Buys Forty Seven

Gilead buys Forty Seven.     Gilead Sciences buys Forty Seven for $4.9 billion.     Forty Seven is a clinical-stage immuno-oncology firm developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on tech licensed from Stanford. Forty Seven’s lead program, magrolimab , is a monoclonal antibody against the CD47 receptor, a ‘don’t eat me’ signal that cancer cells commandeer to avoid being ingested by macrophages. Evaluated ant ibodies are in many clinical studies of patients with myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma, and solid tumors. These assets complement the cell therapy franchise Gilead added with its 2017 buy of Kite Pharma .     Beyond magrolimab , Forty Seven is fixing to advance two more compounds into clinical testing. Developing FSI-174, an anti-cKIT antibody, in combination with magrolimab creates a novel, all-antibody conditioning regimen to address ...
Read more